June 17-19, 2013 | Almas Temple Club | Washington, DC

Our Clients Can't Stop Talking About Infocast

Read the Testimonials

Gold Sponsor

Silver Sponsors






Hospitality Sponsor

Exhibit Sponsors




Media Sponsor

Supporting Organizations

AdvaMedDx
APHA
Biotechnology Industry Assoc
MICHBIO
NCBID
North Carolina Biotechnology Center

Media Partners

absave
B2Bwebinars.net
biosave
Biosecurity and Bioterrorism
DNAvaccine.com
Domestic Prepardness
Global Biodefense
HSToday
Human Vaccines
labsave
Pharma Connections Worldwide

Senior government decision makers share their investment priorities, programs and initiatives for accelerating the pipeline of medical countermeasures against emerging infectious diseases and bioterror threats


Keynote Speaker: Richard Jaffe, Ph.D., MT (ASCP), Director, Division of Medical Countermeasure Strategy and Requirements (MCSR), Office of Policy and Planning (OPP), Office of Assistant Secretary for Preparedness and Response (ASPR), DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)


keynote speakers Michael P. Angelastro
Deputy Director, Division of
Manufacturing, Facilities &
Engineering (MFE), Biomedical
Advanced Research & Development
Authority (BARDA), Office of
the Assistant Secretary for
Preparedness & Response (ASPR)
Paula Bryant, Ph.D.,
Chief, Translational Medical
Division, Chemical and Biological
Technologies Directorate, JSTO
SharíRon de Dreu, M.S.,
Subject Matter Expert, Division
of Clinical Studies (DCS),
Biomedical Advanced Research &
Development Authority (BARDA),
Office of the Assistant Secretary for
Preparedness and Response (ASPR)
Gary Disbrow, Ph.D.,
Deputy Director, Division of
Chemical, Biological, Radiological,
and Nuclear Countermeasures,
Biomedical Advanced Research
and Development Authority
(BARDA), Office of the Assistant
Secretary for Preparedness and
Response (ASPR)
Kristen Herring, Ph.D.,
Lead Science & Technology
Manager, Advanced and Emerging
Threat Division, Chemical
and Biological Technologies
Directorate (CB)
Rosemary Humes, M.S.,
Diagnostics Science Advisor,
Biomedical Advanced Research
and Development Authority
(BARDA), Office of the Assistant
Secretary for Preparedness and
Response (ASPR)
Jamie Johnson,
Director, Office of National
Labs, Science and Technology
Directorate,
DEPARTMENT OF HOMELAND
SECURITY (DHS)
CAPT Estella Jones, D.V.M.,
U.S. Public Health Service,
Regulatory Veterinarian/
Senior Science Advisor,
Office of Counterterrorism
and Emerging Threats, Office
of Chief Scientist, Office of
the Commissioner
Jane Knisely, Ph.D.,
Program Officer Bacteriology
and Mycology Branch,
Division of Microbiology and
Infectious Disease
Michael G Kurilla, M.D., Ph.D.,
Director, Office of Biodefense,
Research Resources and
Translational Research
and Associate Director
for BioDefense Product
Development, Division of
Microbiology and Infectious
Diseases (DMID)
Joseph Larsen, Ph.D.,
Chief, Broad Spectrum
Antimicrobials (BSA)
Program; Division of CBRN
Countermeasure, Biomedical
Advanced Research and
Development Authority
(BARDA), Office of the Assistant
Secretary for Preparedness and
Response (ASPR)
Matthew Lawlor, Ph.D.,
Project Officer and
Interdisciplinary Scientist,
Influenza Division, Biomedical
Advanced Research and
Development Authority
(BARDA), Office of the Assistant
Secretary for Preparedness and
Response (ASPR)
Rachelle Salomon, Ph.D.,
Influenza Vaccines Program
Officer, Respiratory Diseases
Branch, Division of Microbiology
and Infectious Diseases (DMID)
Roxanne Shively, M.S.,
Project Officer, Biomedical
Advanced Research and
Development Authority
(BARDA), Office of the Assistant
Secretary for Preparedness and
Response (ASPR)
Adeyinka Smith, M.S., PMP,
Project Officer, Project Bioshield,
Biomedical Advanced Research
and Development Authority
(BARDA), Office of the Assistant
Secretary for Preparedness and
Response (ASPR)
Eric Van Gieson,
Chief, Diagnostics, Detection and
Disease Surveillance Division
Rodney Wallace,
Chief, CBRN Diagnostics, Division
of CBRN Countermeasures,
Biomedical Advanced Research
and Development Authority
(BARDA), Office of the Assistant
Secretary for Preparedness and
Response (ASPR)


Network with
Key Members of the
Emerging Infectious
Diseases & CBRN
Communities:
Aeras
Battelle
Bavarian Nordic
BioFire Diagnostics, Inc.
Center for Biosecurity at UPMC
Chimerix Inc.
Emergent BioSolutions
EpiVax Inc.
George Mason University
Health Protection Agency
Johns Hopkins Bloomberg
School of Public Health
Texas A&M University System
Tiber Creek Partners
University of Texas Medical
Branch at Galveston
University of Washington The
Networking
Fair
Explore partnership and
collaboration opportunities
June 17-19, 2013
Donít miss the Networking
Fair, an excellent venue
for representatives from
government, biotechnology and
pharmaceutical companies,
research institutions and
universities to come together
and explore opportunities for
partnership and collaboration.
Year after year, attendees have
found the Fair a great value-add
to their conference experience.


The 11th Emerging Infectious Diseases & Biodefense Vaccines, Therapeutics & Diagnostics, scheduled for June 17-19, 2013, will once again provide the latest information on the Federal governmentís biodefense and public health medical countermeasures development, manufacturing and procurement initiatives.

The conference is the ideal venue to interact face-to-face with representatives from Federal agencies tasked with protecting public health. Year after year, the conference brings together the public health and national security agencies, biotech and pharmaceutical industries, and the academic and not-for-profit life CBRN communities to explore strategies for dealing with various challenges, share perspectives, and establish collaboration to further the development of needed medical countermeasures.


Connect with Us
Facebook Twitter LinkedIn GooglePlus

Distributed solar energy projects rising solar power storage production distributed solar network graph